Company Profile Aventis – Summary
This report focuses Global Public-Private Initiatives (GPPIs) for healthcare in developing countries. These GPPIs are a specific type of public-private partnerships. The report assesses company contributions and the rationale for industry involvement with GPPIs. It does not evaluate outcomes or effectiveness, nor does it deal with the governance and functioning of the partnerships in much detail. These issues are addressed in separate reports, focusing on four specific initiatives (GPEI, GAELF, RBM Partnership, Stop TB). Field studies on the implementation of these programmes in developing countries form part of the broader research project.
Partners
-
SOMO
Publicatie
Bijlagen
Related news
-
Bij kankermedicijn Trodelvy is alles gericht op de aandeelhoudersGeplaatst in categorie:Opinie
-
Big Pharma harkte 90 miljard dollar winst binnen met COVID-19 vaccinsGeplaatst in categorie:NieuwsEsther de HaanGepubliceerd op:
-
De pandemiewinsten van de farmaceutische industrie Gepubliceerd op:Esther de HaanGeplaatst in categorie:PublicatieEsther de Haan